Alerna 20 mg (Epinastine Hydrochloride)

Adult dose

Asthma, urticaria, eczema/dermatitis, pruritus, prurigo, and common psoriasis accompanied by pruritus Adults: Administer epinastine hydrochloride 20 mg orally once daily. Adjust the dose appropriately according to symptoms. Allergic rhinitis Adults: Administer 10～20 mg of this medicine orally once daily. Adjust the dose appropriately according to symptoms.

This medication should not be used by individuals who are allergic to this drug or its components. It contains lactose, so it should not be administered to patients with lactose intolerance or certain genetic metabolic disorders. Patients with liver disease, or a history of liver disease, should use this medication cautiously as it may worsen liver condition. If allergic reactions occur while taking this medication, use should be discontinued immediately and medical attention sought. Occasionally, neurogenic symptoms such as drowsiness, headache, dizziness, and insomnia may occur, so caution is necessary. Symptoms of gastrointestinal disturbances may include nausea, abdominal pain, diarrhea, and constipation, so these symptoms should be monitored. Changes in liver function may occur, so periodic checks of liver function tests are important. Rarely, renal atypical symptoms or urinary symptoms may occur, and such symptoms should be reported immediately. Palpitations or respiratory symptoms are also rarely reported, so be cautious if any unusual symptoms occur. This medication is not a fast-acting drug for alleviating asthma attacks, so patients with asthma should be fully informed about its effects and usage. If being treated with steroids for a long time, steroid dosage should be tapered gradually when using this medication. This medication may cause drowsiness, therefore, caution is required when operating machinery or driving. If there is no effect, avoid prolonged use. Women who are pregnant or may become pregnant should carefully consider the risks and benefits when using this medication, and nursing mothers should avoid use if possible or discontinue breastfeeding. Children and the elderly should be used with caution as the safety of this medication has not been fully confirmed or may have deteriorated bodily functions. In case of an overdose, cardiac issues such as arrhythmia may occur, so any symptoms should be reported to medical personnel immediately, and gastric lavage or symptomatic treatment may be necessary. When storing this medication, keep it out of reach of children and do not transfer it to another container. The timing of administration may vary depending on symptoms, so it should be taken before or after meals as directed by a physician.

• Allergic reactions
• rash
• urticaria
• redness
• itching
• swelling
• erythema accompanied by itching
• drowsiness
• lethargy
• headache

This medication should be stored in a sealed container to protect it from air and moisture. It is advisable to maintain a storage temperature between 1 degree and 30 degrees Celsius room temperature.

Appearance

White or pale yellow round film-coated tablet

Package unit

30 tablets/bottle, 100 tablets/bottle